Received Jun 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 4m377 | — |
medication was mixed with sterile water instead of the adjuvant; medication was mixed with sterile water instead of the adjuvant; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 55-year-old female patient who received Herpes zoster (Shingrix) solution for injection (batch number 4m377 with expiry date 26-AUG-2027) for prophylaxis. On 29-MAY-2026, the patient received the 1st dose of Shingrix. On 29-MAY-2026, an unknown time after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution (Verbatim: medication was mixed with sterile water instead of the adjuvant) and inappropriate dose of vaccine administered (Verbatim: medication was mixed with sterile water instead of the adjuvant). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 18-JUN-2026 The patient received their first dose of SHINGRIX and the medication was mixed with sterile water instead of the adjuvant (reconstitution error). The healthcare professional reported the dose was administered to the patient (medication error.)